NVACW
Profusa, Inc.
Key Financials
Operating Income
$-27706000
↓ 1950.7%
Net Income
$-35823000
↓ 311.2%
Revenue
$100000
N/A
EPS (Diluted)
$-107.01
↓ 7179.6%
Total Liabilities
$30.4M
↑ 133.9%
Shareholders' Equity
$-26658000.00
↓ 105.7%
Long-term Debt
$713015.00
N/A
Cash & Equivalents
$1.8M
↑ 10872.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B3 | 5/19/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| PRE 14A | 5/12/2026 | View on SEC |
| 8-K | 5/8/2026 | View on SEC |
| 4 | 5/6/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| EFFECT | 5/4/2026 | View on SEC |
| 424B3 | 5/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NVACW |
| Company Name | Profusa, Inc. |
| CIK | 1859807 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 212-494-9022 |